Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WRD
4501
WeRide Inc
WRD
$2B
| $20.9K | ﹤0.01% |
3,594
-18,161
| -83% | -$131K |
|
4502
Alta Equipment Group
ALTG
$200M
| $20.9K | ﹤0.01% |
3,229
-254
| -7% | -$1.7K |
|
4503
Black Stone Minerals
BSM
$3.16B
| $20.8K | ﹤0.01% |
1,489
-13,023
| -90% | -$181K |
|
|
VNTG
4504
Vantage Corp
VNTG
$18.9M
| $20.6K | ﹤0.01% |
33,210
| – | – |
|
|
SRG
4505
Seritage Growth Properties
SRG
$115M
| $20.5K | ﹤0.01% |
7,795
+220
| +3% | +$578 |
|
|
RAAY
4506
Reckoner Yield Enhanced AAA CLO Annual ETF
RAAY
$15.4M
| $20.4K | ﹤0.01% |
200
| – | – |
|
4507
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.75B
| $20.3K | ﹤0.01% |
805
| – | – |
|
4508
Greenwich LifeSciences
GLSI
$233M
| $19.9K | ﹤0.01% |
850
-309
| -27% | -$7.52K |
|
4509
Prairie Operating Co
PROP
$52.8M
| $19.9K | ﹤0.01% |
27,516
-402
| -1% | -$433 |
|
4510
Innovator US Equity Power Buffer ETF January
PJAN
$1.42B
| $19.8K | ﹤0.01% |
+400
| New | +$19.5K |
|
|
NSCI
4511
Nuveen Securitized Income ETF
NSCI
$230M
| $19.7K | ﹤0.01% |
+779
| New | +$19.6K |
|
|
ALFUU
4512
Centurion Acquisition Corp Unit
ALFUU
| $19.5K | ﹤0.01% |
1,791
| – | – |
|
4513
Armata Pharmaceuticals
ARMP
$216M
| $19.3K | ﹤0.01% |
2,984
+2,830
| +1,838% | +$26K |
|
|
AUTL
4514
Autolus Therapeutics
AUTL
$562M
| $19.1K | ﹤0.01% |
11,939
+3,865
| +48% | +$6.06K |
|
|
CGC
4515
Canopy Growth
CGC
$434M
| $19K | ﹤0.01% |
20,003
+16,800
| +525% | +$17.8K |
|
|
KLC
4516
KinderCare Learning Companies
KLC
$306M
| $18.9K | ﹤0.01% |
4,456
-1,144
| -20% | -$4.22K |
|
4517
Douglas Elliman
DOUG
$162M
| $18.9K | ﹤0.01% |
10,657
-4,342
| -29% | -$7.79K |
|
4518
TScan Therapeutics
TCRX
$23.4M
| $18.8K | ﹤0.01% |
19,170
+2,090
| +12% | +$2.23K |
|
4519
UNIFI
UFI
$126M
| $18.8K | ﹤0.01% |
3,950
+79
| +2% | +$314 |
|
4520
Oppenheimer Holdings
OPY
$1.32B
| $18.7K | ﹤0.01% |
177
-162
| -48% | -$16.5K |
|
4521
Future Fuel
FF
$234M
| $18.6K | ﹤0.01% |
4,123
-545
| -12% | -$2.35K |
|
|
ATYR
4522
aTyr Pharma
ATYR
$47.2M
| $18.5K | ﹤0.01% |
31,029
-14,094
| -31% | -$9.21K |
|
4523
Intellicheck
IDN
$55.3M
| $18.4K | ﹤0.01% |
4,495
-6,272
| -58% | -$37.6K |
|
4524
Digimarc Corp
DMRC
$119M
| $18.2K | ﹤0.01% |
2,212
-778
| -26% | -$7.31K |
|
|
SPTX
4525
Seaport Therapeutics
SPTX
$1.29B
| $18.2K | ﹤0.01% |
+837
| New | +$14.7K |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.